@inproceedings{inproceedings, title  = {{Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment}},

 publisher = {{MDPI}},

 url = {{http://dx.doi.org/10.3390/iecc2021-09209 }},

 year = {{2021}},

 month = {{1}},

 author = {{Ślusarczyk A and Bryant HE and Chen E and Hitchcock I and Zeidler M and Chantry A and Thomas S}},

 doi = {{10.3390/iecc2021-09209}},

 volume = {{129}},

 journal = {{The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response}},

 pages = {{17-17}},

 note = {{Accessed on 2024/12/22}}}